体内
大麻酚
吉西他滨
体外
药理学
癌症
旁观者效应
癌症研究
化学
未折叠蛋白反应
医学
内科学
生物
细胞凋亡
生物化学
免疫学
生物技术
大麻
精神科
作者
Thatsanapong Pongking,Phonpilas Thongpon,Kitti Intuyod,Sirinapha Klungsaeng,Raynoo Thanan,Apisit Chaidee,Naruechar Charoenram,Suppakrit Kongsintaweesuk,Chadamas Sakonsinsiri,Kulthida Vaeteewoottacharn,Somchai Pinlaor,Porntip Pinlaor
标识
DOI：10.1186/s12906-024-04610-2
摘要
Failure of treatment with gemcitabine in most cholangiocarcinoma (CCA) patients is due to drug resistance. The therapeutic potential of natural plant secondary compounds with minimal toxicity, such as cannabidiol (CBD), is a promising line of investigation in gemcitabine-resistant CCA. We aim to investigate the effects of CBD on gemcitabine-resistant CCA (KKU-213B
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
MchemG
不配.
非而者厚
带头大哥
AireenBeryl531
null
Billy
核桃
GingerF
scm
plum
忧心的曼凝
jyy
灯光师
yydragen
CAOHOU
汉堡包
MYFuture
chenyue233
yyds
皖公网安备34019202002308
